Cell therapies using mesenchymal stromal cells (MSCs) have been proposed as a promising new tool for the treatment of vocal fold scarring. However, the mechanisms by which MSCs promote healing as well as their duration of survival within the host vocal fold have yet to be defined. The aim of this work was to assess the persistence of embedded MSCs within a tissue-engineered vocal fold mucosal replacement in a rabbit model of vocal fold injury.
Methods:
Male rabbit adipose-derived MSCs were embedded within a 3-dimensional fibrin gel, forming the cell-based outer vocal fold replacement. Four female rabbits underwent unilateral resection of vocal fold epithelium and lamina propria and reconstruction with cell-based outer vocal fold replacement implantation. Polymerase chain reaction and fluorescent in situ hybridization for the sex-determining region of the Y chromosome (SRY-II) in the sex-mismatched donor-recipient pairs sought persistent cells after 4 weeks.
Results:
A subset of implanted male cells was detected in the implant site at 4 weeks. Many SRY-II-negative cells were also detected at the implant site, presumably representing native female cells that migrated to the area. No SRY-II signal was detected in contralateral control vocal folds.
Conclusions:
The emergent tissue after implantation of a tissue-engineered outer vocal fold replacement is derived both from initially embedded adipose-derived stromal cells and infiltrating native cells. Our results suggest this tissue-engineering approach can provide a well-integrated tissue graft with prolonged cell activity for repair of severe vocal fold scars.
ZukPZhuMMizunoHet al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7(2):211-228.
2.
PittengerMFMackayAMBeckSCet al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143-147.
3.
ShibaTLHardyJLuegmairGZhangZLongJL. Tissue-engineered vocal fold mucosa implantation in rabbits. Otolaryngol Head Neck Surg. 2016;154(4):679-688.
4.
LongJL. Repairing the vibratory vocal fold. Laryngoscope. 2018;128(1):153-159.
5.
HiranoSBlessDRousseauBet al. Prevention of vocal fold scarring by topical injection of hepatocyte growth factor in a rabbit model. Laryngoscope. 2004;114:548-556.
6.
ChengSLZhangSFMohanSet al. Regulation of insulin-like growth factors I and II and their binding proteins in human bone marrow stromal cells by dexamethasone. J Cell Biochem. 1998;71(3):449-458.
7.
WeimarISVoremansCBourhisJHet al. Hepatocyte growth factor/scatter factor (HGF/SF) affects proliferation and migration of myeloid leukemic cells. Leukemia. 1998;12(8):1195-1203.
8.
CedervallJAhrlund-RichterLSvenssonBet al. Injection of embryonic stem cells into scarred rabbit vocal folds enhances healing and improves viscoelasticity: short-term results. Laryngoscope. 2007;117(11):2075-2081.
9.
ChimentiISmithRRLiTSet al. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ Res. 2010;106(5):971-980.
10.
LiTSChengKMalliarasKet al. Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells. J Am Coll Cardiol. 2012;59(10):942-953.
11.
FurutaTMiyakiSIshitobiHet al. Mesenchymal stem cell-derived exosomes promote fracture healing in a mouse model. Stem Cells Transl Med. 2016;5(12):1620-1630.
12.
HiwatashiNHiranoSMizutaMet al. Adipose-derived stem cells versus bone marrow-derived stem cells for vocal fold regeneration. Laryngoscope. 2014;124(12):E461-E469.
13.
de BonnecazeGChaputBWoisardVet al. Adipose stromal cells improve healing of vocal fold scar: Morphological and functional evidences. Laryngoscope. 2016;126(8):E278-E285.
14.
LiangQLiuSHanPet al. Micronized acellular dermal matrix as an efficient expansion substrate and delivery vehicle of adipose-derived stem cells for vocal fold regeneration. Laryngoscope. 2012;122(8):1815-1825.
15.
BrazeltonTRBlauHM. Optimizing techniques for tracking transplanted stem cells in vivo. Stem Cells. 2005;23(9):1251-1265.
16.
TothZEShaharTLekerRet al. Sensitive detection of GFP utilizing tyramide signal amplification to overcome gene silencing. Exp Cell Res. 2007;313(9):1943-1950.
17.
TerrovitisJVSmithRRMarbanE. Assessment and optimization of cell engraftment after transplantation into the heart. Circ Res. 2010;106(3):479-494.
18.
ShibaTHardyJLongJChatzistefanouI. Laryngeal tissue engineering using rabbit adipose derived stem cells in fibrin: a pre-clinical model. J Otolaryngol Adv. 2015;1(1):27-39.
19.
LongJLZukPBerkeGSChhetriDK. Epithelial differentiation of adipose-derived stem cells for laryngeal tissue engineering. Laryngoscope. 2010;120(1):125-131.
PutzeMNürnbergSFickelJ. Y-chromosomal markers for the European brown hare (Lepus europaeus, Pallas 1778). Eur J Wildlife Res. 2007;53(4):257-264.
22.
HiwatashiNHiranoSSuzukiRet al. Comparison of ASCs and BMSCs combined with atelocollagen for vocal fold scar regeneration. Laryngoscope. 2016;126(5):1143-1150.
23.
KanemaruSNakamuraTOmoriKet al. Regeneration ofthe vocal fold using autologous mesenchymal stem cells. Ann Otol Rhinol Laryngol. 2003;112(11):915-920.
SuehiroAHiranoSKishimotoYTateyaIRouzzeauBItoJ. Effects of basic fibroblast growth factor on rat vocal fold fibroblasts. Ann Otol Rhinol Laryngol. 2010;119(10):690-696.
26.
SvenssonBNagubothuRSCedervallJet al. Injection of human mesenchymal stem cells improves healing of scarred vocal folds: analysis using a xenograft model. Laryngoscope. 2010;120(7):1370-1375.
27.
ThibeaultSLKiemukSASmithMELeugersCPrestwichG. In vivo comparison of biomimetic approaches for tissue regeneration of the scarred vocal fold. Tissue Eng Part A. 2009;15(7):1481-1487.
28.
XuWHuRFanEHanD. Adipose-derived mesenchymal stem cells in collagen–hyaluronic acid gel composite scaffolds for vocal fold regeneration. Ann Otol Rhinol Laryngol. 2011;120(2):123-130.
29.
LimJYKimHSKimYHKimKMChoiHS. PMMA (polymethylmetacrylate) microspheres and stabilized hyaluronic acid as an injection laryngoplasty material for the treatment of glottal insufficiency: in vivo canine study. Eur Arch Otorhinolaryngol. 2008;265(3):321-326.
AhearneMKellyDJ. A comparison of fibrin, agarose and gellan gum hydrogels as carriers of stem cells and growth factor delivery microspheres for cartilage regeneration. Biomed Mater. 2013;8(3):035004.
32.
CoccoRUckerDS. Distinct modes of macrophage recognition for apoptotic and necrotic cells are not specified exclusively by phosphatidylserine exposure. Mol Biol Cell. 2001;12(4):919-930.
33.
MeliefSMZwagingaJJFibbeWERoelofsH. Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts. Stem Cells Transl Med. 2013;2(6):455-463.
34.
NiemeyerPKornackerMMehlhornAet al. Comparison of immunological properties of bone marrow stromal cells and adipose tissue-derived stem cells before and after osteogenic differentiation in vitro. Tissue Eng. 2007;13(1):111-121.
35.
CandinasDGunsonBNightingalePHubscherSMcMasterPNeubergerJM. Sex mismatch as a risk factor for chronic rejection of liver allografts. Lancet. 1995;346(8983):1117-1121.
36.
LiZMeiSXiangJet al. Influence of donor-recipient sex mismatch on long-term survival of pancreatic grafts. Sci Rep. 2016;6:29298.
37.
TanJCWadiaPPCoramMet al. H-Y antibody development associates with acute rejection in female patients with male kidney transplants. Transplantation. 2008;86(1):75-81.
38.
KleinSLFlanaganKL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626-638.
